background
activ
reninangiotensin
system
ra
play
critic
role
pathophysiolog
myocardi
infarct
mi
develop
heart
failur
angiotensinconvert
enzym
insulininsulin
receptor
show
cardioprotect
effect
acut
mi
arg
polymorph
associ
diminish
activ
insulin
present
studi
explor
associ
among
arg
acut
mi
serum
level
method
total
subject
includ
subject
firsttim
acut
mi
subject
without
histori
mi
genotyp
arg
polymorph
serum
level
mi
sever
score
determin
primari
human
cardiomyocyt
overexpress
wild
type
arg
knockdown
endogen
expos
normoxia
hypoxia
express
level
determin
result
serum
level
significantli
increas
acut
mi
patient
compar
nonmi
control
compar
wild
type
carrier
arg
carrier
exhibit
decreas
serum
level
increas
mi
sever
score
mi
vitro
data
demonstr
impair
signal
overexpress
arg
knockdown
endogen
inhibitor
abolish
hypoxiainduc
activ
express
human
cardiomyocyt
suggest
causal
relationship
arg
decreas
serum
level
acut
mi
patient
vitro
data
also
indic
signal
requir
express
cardiomyocyt
hypoxia
enhanc
induct
effect
signal
express
cardiomyocyt
conclus
studi
provid
first
evid
crosstalk
signal
ra
acut
mi
therebi
ad
fresh
insight
pathophysiolog
treatment
acut
mi
activ
reninangiotensin
system
ra
play
critic
role
pathophysiolog
myocardi
infarct
mi
develop
heart
failur
ra
blockad
angiotensinconvert
enzym
ace
inhibitor
improv
cardiac
remodel
outcom
experiment
model
mi
well
human
ace
metabol
angiotensin
ang
form
ang
ii
key
import
pathophysiolog
ra
heart
recent
new
member
ra
found
function
neg
regul
ang
system
metabol
ang
ii
put
protect
peptid
ang
high
effici
present
heart
reduct
express
associ
enhanc
cardiac
hypertrophi
reduc
pump
abil
although
initi
local
exclus
cardiac
endotheli
cell
recent
studi
demonstr
immunoreact
endotheli
smooth
muscl
cell
myocardi
vessel
well
cardiomyocyt
mi
signific
activ
cardiac
rat
human
act
combat
advers
effect
activ
cardiac
ra
evid
cardioprotect
role
aris
studi
mice
loss
facilit
advers
postmi
ventricular
remodel
studi
show
overexpress
mi
rat
improv
cardiac
contractil
remodel
report
serum
activ
rise
first
week
follow
acut
mi
activ
may
compensatori
mechan
advanc
heart
failur
insulin
benefici
effect
cardiomyocyt
function
surviv
includ
protect
acut
ischem
injuri
insulin
signal
promot
glucos
uptak
glycolyt
flux
glucos
oxid
improv
ischem
toler
heart
protect
effect
insulin
heart
mediat
via
activ
signal
pathway
involv
insulin
receptor
insulin
receptor
kinas
previou
studi
demonstr
common
polymorph
gene
arg
polymorph
glyarg
substitut
take
place
codon
arg
associ
impair
abil
activ
downstream
factor
kinas
lead
diminish
activ
insulin
result
one
pilot
studi
suggest
arg
polymorph
might
associ
activ
mi
patient
present
studi
explor
associ
among
arg
acut
mi
serum
level
rel
larg
sampl
acut
mi
patient
aim
identifi
potenti
interact
signal
ra
pathophysiolog
acut
mi
juli
octob
subject
firsttim
acut
mi
mean
age
year
rang
year
recruit
studi
second
xiangya
hospit
central
south
univers
inclus
criteria
patient
undergon
first
attack
stelev
myocardi
infarct
stemi
verbal
communic
agre
particip
studi
subject
without
histori
mi
mean
age
year
rang
year
enrol
control
subject
congenit
heart
diseas
exclud
blood
sampl
drawn
day
post
mi
acut
mi
subject
day
control
consent
particip
studi
blood
sampl
subject
elisa
assay
serum
level
studi
approv
ethic
committe
second
xiangya
hospit
central
south
univers
written
inform
consent
obtain
particip
start
studi
arg
polymorph
identifi
restrict
fragment
length
polymorph
previous
describ
three
singl
nucleotid
polymorph
snp
select
proxi
studi
polymorph
previous
describ
use
predict
risk
death
cardiac
diseas
tool
predict
score
creat
index
sever
previous
describ
use
provid
simpl
longterm
admissionday
prognost
score
patient
hospit
mi
unstabl
angina
score
compon
includ
shock
point
clinic
histori
mi
stroke
angina
point
age
point
ecg
find
point
congest
heart
failur
point
charlson
comorbid
index
point
maximum
sever
score
point
fragment
human
genom
dna
contain
entir
code
sequenc
clone
ligat
express
vector
previous
describ
express
vector
construct
previous
describ
transfect
reagent
purchas
qiagen
valencia
ca
usa
trizol
reagent
rna
isol
sybr
green
master
mix
purchas
invitrogen
carlsbad
ca
usa
pe
appli
biosystem
foster
citi
ca
usa
respect
short
hairpin
rna
shrna
lentivir
particl
control
shrna
lentivir
particlesa
antibodi
purchas
santa
cruz
biotechnolog
santa
cruz
ca
usa
human
elisa
kit
purchas
adipogen
san
diego
ca
usa
tace
activ
assay
kit
purchas
anaspec
fremont
ca
usa
puromycin
chemic
reagent
grade
purchas
sigma
st
loui
mo
usa
cell
cultur
lentivir
transduct
transfect
cdna
applic
hypoxia
treatment
human
adult
cardiomyocyt
cardiomyocyt
medium
purchas
sciencel
research
laboratori
carlsbad
ca
usa
lentivir
transduct
perform
human
cardiomyocyt
shrna
lentivir
particl
contain
express
construct
encod
targetspecif
nt
plu
hairpin
shrna
design
specif
knock
gene
express
control
shrna
lentivir
particl
contain
scrambl
shrna
sequenc
lead
degrad
cellular
mrna
use
neg
control
shrna
lentivir
particl
pool
stabl
transduct
gener
via
select
puromycin
manufactur
protocol
santa
cruz
biotechnolog
human
cardiomyocyt
stabli
transfect
empti
plasmid
use
transfect
reagent
qiagen
accord
manufactur
instruct
pool
stabl
transfect
gener
via
select
puromycin
manufactur
protocol
hypoxia
treatment
cell
respect
kept
hour
serumfre
medium
without
mgl
insulin
rna
human
cardiomyocyt
prepar
use
trizol
reagent
follow
purif
turbo
dnafre
system
ambion
austin
tx
usa
cdna
synthes
use
superscript
ii
revers
transcriptas
invitrogen
realtim
quantit
pcr
perform
abipr
sequenc
detect
system
appli
biosystem
use
fluoresc
dye
sybr
green
master
mix
pe
appli
biosystem
describ
manufactur
result
normal
housekeep
gene
dehydrogenas
gapdh
sampl
primer
use
follow
gttctctg
forward
cacaaaa
revers
gapdh
forward
revers
experi
repeat
three
time
triplic
human
cardiomyocyt
lyse
l
sd
load
buffer
mm
trishcl
ph
sd
glycerol
bromphenol
blue
incub
min
equal
amount
protein
sampl
separ
sdspolyacrylamid
gel
blot
onto
polyvinyliden
difluorid
micropor
membran
millipor
billerica
usa
membran
incub
hour
dilut
primari
antibodi
wash
reveal
use
secondari
antibodi
horseradish
peroxidas
conjug
hour
peroxidas
reveal
ge
healthcar
ecl
kit
protein
quantifi
load
onto
gel
activ
determin
previous
describ
briefli
total
protein
immunoprecipit
antibodi
santa
cruz
biotechnolog
inc
kinas
activ
detect
appear
radiolabel
plabel
phosphatidylinositol
p
tlc
describ
autoradiograph
signal
quantit
use
nih
imag
version
statist
analys
carri
use
ibm
chicago
il
usa
continu
variabl
valu
express
comparison
mean
two
independ
group
perform
student
ttest
comparison
serum
level
acut
mi
genotyp
group
perform
pair
ttest
comparison
serum
level
acut
mi
two
genotyp
group
perform
analysi
covari
use
serum
level
acut
mi
covari
comparison
mean
among
multipl
group
perform
oneway
anova
follow
post
hoc
pairwis
comparison
use
tukey
test
categor
variabl
compar
chisquar
test
main
effect
interact
among
arg
mi
serum
level
analyz
anova
signific
level
studi
set
twotail
total
subject
subject
firsttim
acut
stemi
control
without
histori
mi
blood
sampl
collect
day
mi
acut
mi
subject
shown
tabl
acut
mi
subject
control
compar
age
bmi
blood
lipid
except
lowdens
lipoprotein
cholesterol
triglycerid
blood
pressur
insulin
sensit
shown
tabl
subject
control
acut
mi
group
homozyg
arg
aa
carrier
number
arg
homozygot
small
gener
result
adequ
statist
power
combin
arg
homozygot
aa
heterozygot
ga
one
group
gaaa
compar
wild
type
gg
group
addit
acut
mi
subject
nonmi
control
show
margin
signific
differ
gender
profil
perform
genderstratifi
comparison
control
subject
acut
mi
subject
minim
potenti
confound
effect
gender
signific
differ
allel
frequenc
acut
mi
subject
nonmi
control
subject
total
gender
tabl
indic
arg
mutat
signific
contributor
acut
mi
shown
tabl
serum
level
significantli
higher
acut
mi
subject
control
subject
p
signific
differ
serum
level
gg
gaaa
genotyp
group
control
subject
howev
acut
mi
subject
gaaa
genotyp
group
significantli
lower
serum
level
higher
mi
sever
score
gg
genotyp
group
p
signific
gender
differ
find
shown
tabl
anova
analysi
whole
cohort
subject
control
stemi
subject
discontinu
covari
acut
mi
reveal
acut
mi
arg
genotyp
contribut
significantli
varianc
serum
level
addit
arg
genotyp
acut
mi
show
signific
interact
contribut
varianc
serum
level
result
suggest
acut
mi
arg
carrier
tend
decreas
serum
level
wild
type
carrier
acut
mi
subject
blood
drawn
studi
occurr
mi
next
examin
serum
level
subject
mi
shown
tabl
serum
level
gaaa
genotyp
group
similar
gg
genotyp
group
acut
mi
howev
occurr
acut
mi
gaaa
genotyp
group
significantli
lower
serum
level
gg
genotyp
group
p
signific
gender
differ
find
taken
togeth
result
indic
presenc
arg
lead
significantli
reduc
serum
level
sever
mi
acut
mi
patient
independ
gender
explor
potenti
causal
relationship
arg
serum
level
acut
mi
subject
perform
vitro
experi
use
human
cardiomyocyt
treat
hypoxia
express
vector
wild
type
arg
stabli
transfect
cardiomyocyt
endogen
stabli
knock
shrna
shown
figur
stabli
transfect
cell
show
mark
increas
protein
detect
antibodi
indic
wild
type
arg
overexpress
transfect
cardiomyocyt
compar
cell
stabli
transduc
scrambl
control
shrna
cell
stabli
transduc
shrna
show
knockdown
endogen
figur
realtim
quantit
rtpcr
show
absenc
insulin
mrna
level
remain
basal
level
experiment
group
either
normoxia
hypoxia
tabl
presenc
insulin
mgl
mrna
level
significantli
elev
control
normoxia
overexpress
wild
type
arg
significantli
chang
mrna
level
shrna
inhibitor
abolish
insulininduc
elev
mrna
level
tabl
cardiomyocyt
expos
hypoxia
simul
oxygen
depriv
mi
hour
cultur
hypoxia
plu
insulin
mgl
control
cell
show
significantli
elev
mrna
level
compar
control
normoxiainsulin
tabl
overexpress
arg
markedli
decreas
mrna
level
cardiomyocyt
hypoxia
tabl
shrna
abolish
induct
mrna
insulin
plu
hypoxia
tabl
result
confirm
protein
level
western
blot
analys
also
show
express
constitut
low
level
cardiomyocyt
normoxia
figur
elisa
show
secretedsolubl
level
cultur
media
cardiomyocyt
follow
data
trend
tabl
find
indic
signal
requir
express
cardiomyocyt
hypoxia
markedli
enhanc
induct
effect
signal
express
cardiomyocyt
reportedli
shed
sheddas
produc
solubl
express
reportedli
regul
hypoxia
next
examin
shed
activ
human
cardiomyocyt
experiment
condit
tabl
shown
figur
shed
activ
significantli
upregul
hypoxia
cardiomyocyt
howev
overexpress
knockdown
overexpress
arg
inhibit
show
signific
effect
activ
cardiomyocyt
without
insulin
indic
insulin
signal
signific
effect
shed
activ
cardiomyocyt
therefor
effect
arg
express
cardiomyocyt
involv
shed
mechan
addit
found
associ
arg
variant
genotyp
femal
acut
mi
patient
haplotyp
ggc
male
acut
mi
patient
data
shown
shown
figur
absenc
insulin
activ
remain
basal
level
experiment
group
either
normoxia
hypoxia
presenc
insulin
mgl
activ
significantli
elev
control
normoxia
overexpress
arg
slightli
decreas
activ
shrna
abolish
insulininduc
elev
activ
presenc
hypoxia
plu
insulin
mgl
control
cell
show
markedli
elev
activ
compar
control
normoxia
insulin
overexpress
arg
markedli
decreas
activ
cardiomyocyt
hypoxia
shrna
abolish
induct
activ
insulin
plu
hypoxia
result
indic
hypoxia
significantli
enhanc
activ
word
signal
cardiomyocyt
present
studi
found
arg
associ
decreas
serum
level
acut
mi
patient
vitro
data
reveal
presenc
insulin
arg
inhibit
express
human
cardiomyocyt
hypoxia
previou
studi
show
serum
activ
significantli
increas
baselin
day
stemi
patient
day
signific
direct
correl
observ
activ
infarct
size
left
ventricular
function
index
thu
present
studi
measur
serum
level
day
acut
mi
preliminari
studi
nonstemi
subject
show
inconsist
serum
level
therefor
stemi
subject
enrol
present
studi
express
heart
reportedli
play
protect
role
mi
increas
evid
show
express
cardiac
increas
mi
act
combat
advers
effect
activ
cardiac
ra
therefor
may
compensatori
mechan
mi
agreement
subject
blood
sampl
collect
mi
observ
signific
increas
serum
level
mi
arg
carrier
significantli
lower
serum
level
higher
mi
sever
score
compar
wild
carrier
mi
confirm
cardioprotect
role
increas
level
mi
find
also
suggest
import
role
signal
increas
express
mi
sinc
arg
associ
impair
abil
activ
lead
diminish
activ
insulin
demonstr
vitro
shed
mechan
involv
effect
arg
express
cardiomyocyt
suggest
signal
directli
target
express
myocardi
hypoxia
major
factor
pathophysiolog
mi
thought
prime
determin
progress
heart
failur
thu
subsequ
vitro
experi
investig
potenti
causal
relationship
arg
express
expos
primari
human
cardiomyocyt
hypoxia
agreement
vivo
data
express
mrna
proteinsolubl
protein
level
increas
hypoxia
compar
normoxia
abolish
overexpress
arg
knock
endogen
inhibitor
insulin
signal
improv
ischem
toler
heart
via
activ
signal
pathway
involv
insulin
receptor
insulin
receptor
vitro
data
indic
hypoxia
significantli
enhanc
activ
therebi
signal
figur
western
blot
analysi
express
human
cardiomyocyt
human
cardiomyocyt
stabli
transfect
wild
type
wt
arg
stabli
transduc
human
cardiomyocyt
stabli
transfect
empti
plasmid
vc
stabli
transduc
scrambl
control
shrna
sc
use
control
cell
lysat
subject
western
blot
analysi
use
antibodi
blot
use
load
control
b
protein
blot
measur
densitometri
densiti
blot
normal
obtain
rel
blot
densiti
p
compar
vc
tabl
rel
mrna
level
angiotensinconvert
enzym
human
cardiomyocyt
normoxia
hypoxia
without
insulin
treatment
cardiomyocyt
western
blot
analysi
result
show
express
constitut
low
level
cardiomyocyt
normoxia
may
explain
overexpress
arg
signific
effect
express
cardiomyocyt
normoxia
small
amount
endogen
wild
type
cell
may
well
suffic
basal
level
signal
express
despit
competit
arg
activ
need
wild
type
significantli
increas
hypoxia
cardiomyocyt
howev
competit
overexpress
arg
would
manifest
signific
inhibitori
effect
signal
therebi
express
may
explain
arg
carrier
acut
mi
show
decreas
serum
level
recent
discoveri
influenc
local
tissu
ra
skelet
muscl
heart
vasculatur
adipocyt
pancrea
led
improv
understand
activ
tissu
ra
influenc
develop
insulin
resist
diabet
human
studi
suggest
lysat
subject
western
blot
analysi
express
lane
normoxia
lane
hypoxia
lysat
human
cardiomyocyt
stabli
transfect
empti
plasmid
use
control
vc
lane
vc
lane
cardiomyocyt
stabli
transfect
lane
cardiomyocyt
stabli
transfect
lane
cardiomyocyt
stabli
transduc
lane
vc
cell
treat
ly
hour
blot
use
load
control
b
blot
measur
densitometri
densiti
blot
normal
obtain
rel
blot
densiti
express
fold
chang
vc
cell
normoxia
design
p
compar
group
normoxia
p
compar
vc
normoxia
b
p
compar
normoxia
c
p
compar
normoxia
p
compar
normoxia
e
p
compar
vcli
normoxia
f
p
compar
vc
hypoxia
g
p
compar
hypoxia
h
p
compar
hypoxia
signal
involv
regul
local
ra
heart
may
novel
topic
field
cardiolog
diabetolog
sever
limit
present
studi
increas
serum
level
acut
mi
subject
could
multipl
sourc
vascular
smooth
muscl
cell
endotheli
cell
cardiomyocyt
use
cardiomyocyt
vitro
identifi
causal
relationship
arg
serum
level
acut
mi
subject
increas
level
secret
solubl
cultur
media
cardiomyocyt
hypoxia
suggest
cardiomyocytesecret
could
least
partial
account
increas
serum
level
acut
mi
patient
howev
would
interest
futur
studi
explor
effect
signal
express
cell
type
mani
pathophysiolog
factor
involv
acut
mi
besid
hypoxia
explor
effect
signal
express
hypoxia
normoxia
would
interest
investig
signal
regul
express
influenc
condit
involv
acut
mi
eg
increas
cardiomyocyt
apoptosi
inflammatori
respons
etc
nevertheless
base
vivo
vitro
data
shown
potenti
causal
relationship
arg
serum
level
acut
mi
patient
find
suggest
signal
exert
cardioprotect
effect
acut
mi
least
partial
increas
express
agreement
arg
impair
signal
result
decreas
express
acut
mi
lead
sever
mi
thu
insulin
signal
could
potenti
new
target
acut
mi
therapi
addit
studi
suggest
special
attent
paid
acut
mi
patient
carri
arg
tend
sever
mi
poorer
prognosi
carri
wild
type
conclus
vivo
data
indic
arg
associ
decreas
serum
level
acut
mi
patient
vitro
data
demonstr
impair
signal
overexpress
arg
knockdown
endogen
inhibitor
abolish
hypoxiainduc
activ
express
human
cardiomyocyt
suggest
causal
relationship
arg
decreas
serum
level
acut
mi
patient
vitro
data
also
indic
signal
requir
express
cardiomyocyt
hypoxia
markedli
enhanc
induct
effect
signal
express
cardiomyocyt
studi
provid
first
evid
crosstalk
signal
ra
acut
mi
therebi
ad
fresh
insight
pathophysiolog
treatment
acut
mi
